tradingkey.logo

Biote Corp

BTMD
查看詳細走勢圖
1.280USD
-0.070-5.19%
交易中 美東報價延遲15分鐘
10.67M總市值
1.48本益比TTM

Biote Corp

1.280
-0.070-5.19%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-5.19%

5天

-16.34%

1月

-39.62%

6月

-57.19%

今年開始到現在

-50.77%

1年

-62.24%

查看詳細走勢圖

TradingKey Biote Corp股票評分

單位: USD 更新時間: 2026-03-27

操作建議

Biote Corp當前公司基本面數據相對健康,最新ESG揭露屬於行業領先水平。增長潛力較大。當前估值合理,在專業與商業服務行業排名84/159位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為3.17。中期看,股價處於下降通道。近一個月,市場表現非常差,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Biote Corp評分

相關信息

行業排名
84 / 159
全市場排名
220 / 4542
所屬行業
專業與商業服務

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

Biote Corp亮點

亮點風險
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
利潤高增長
公司淨利潤處於行業前列,最新年度總收入192.22M美元
估值低估
公司最新PE估值1.53,處於3年歷史低位
機構減倉
最新機構持股20.37M股,環比減少0.13%
PRFDX持倉
明星投資者PRFDX持倉,最新持倉2.54K股
活躍度增加
近期活躍度增加,過去20天平均換手率0.51

分析師目標

基於 5 分析師
買入
評級
3.174
目標均價
+135.11%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Biote Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Biote Corp簡介

biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
公司代碼BTMD
公司Biote Corp
CEOChristensen (Bret)
網址https://haymakeracquisition.com/
KeyAI